Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioadaptives (BDPT) Long-Term Debt Issuances (2019 - 2024)

Bioadaptives' Long-Term Debt Issuances history spans 5 years, with the latest figure at $80000.0 for Q4 2023.

  • For Q4 2023, Long-Term Debt Issuances rose 128.57% year-over-year to $80000.0; the TTM value through Sep 2025 reached $80000.0, changed 0.0%, while the annual FY2024 figure was $32096.0, 59.88% down from the prior year.
  • Long-Term Debt Issuances for Q4 2023 was $80000.0 at Bioadaptives, up from $35000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $203377.0 in Q3 2021 and bottomed at -$48377.0 in Q2 2022.
  • The 5-year median for Long-Term Debt Issuances is $42500.0 (2022), against an average of $52316.7.
  • The largest annual shift saw Long-Term Debt Issuances crashed 35.0% in 2021 before it surged 2980.71% in 2022.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $15800.0 in 2019, then soared by 406.33% to $80000.0 in 2020, then plummeted by 35.0% to $52000.0 in 2021, then crashed by 32.69% to $35000.0 in 2022, then surged by 128.57% to $80000.0 in 2023.
  • Per Business Quant, the three most recent readings for BDPT's Long-Term Debt Issuances are $80000.0 (Q4 2023), $35000.0 (Q4 2022), and $158377.0 (Q3 2022).